Zydus Therapeutics announces positive topline results from EPICS-III Phase 2b/3 trial of…
EPICS-III trial met primary and secondary endpoints in evaluating Saroglitazar for Primary Biliary Cholangitis patients with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sai Life Sciences completes Phase II expansion of production block PB-11 at Bidar facility
The expansion increases total reactor capacity to ~700 KL, supporting large-scale API and intermediate manufacturing for regulated…
TCS partners with Unilab for cloud-based ERP transformation in the Philippines
TCS to implement SAP S/4HANA on RISE to modernise Unilab’s core systems and strengthen its digital infrastructure
FDA approves Pfizer-BioNTech LP.8.1-adapted monovalent COVID-19 vaccine for high-risk groups
The vaccine is approved for adults aged 65 years and older and individuals aged 5 to 64 years with underlying conditions
Eli Lilly announces Phase 3 ATTAIN-2 trial results for oral GLP-1 agonist orforglipron in obesity…
ATTAIN-2 met primary and key secondary endpoints, with weight loss, A1C reductions, and cardiometabolic improvements at 72 weeks
Dr Reddy’s launches Linaclotide for chronic constipation treatment in India
Dr Reddy’s introduces Colozo, the first guanylate cyclase-C agonist approved in India for adults with chronic idiopathic…
Novartis and BioArctic sign collaboration agreement on BrainTransporter technology for neurological…
Novartis may license drug candidate from collaboration with BioArctic, with potential payments of up to USD 772 million and…
Industry expert calls for GST parity to support MSMEs and strengthen India’s position as the…
Bhavin Mehta, Vice Chairman of Pharmexcil, highlights how addressing GST inversion challenges through rate alignment and targeted…
GSK introduces Jemperli and Zejula in India to expand oncology portfolio
Jemperli approved for second-line treatment of advanced endometrial cancer; Zejula approved as first-line maintenance monotherapy…
Technology-driven regulatory landscape
Ravi Sharma explains how technology is reshaping regulatory affairs, highlighting the growing role of AI, harmonisation efforts,…
Eris Lifesciences secures ANVISA approval for Ahmedabad manufacturing unit
ANVISA inspection in May 2025 enables Eris Lifesciences’ entry into Brazil’s pharma market
US eosinophilic esophagitis market to reach $1.19 billion by 2030, forecasts GlobalData
Market growth driven by FDA-approved therapies Dupixent, Eohilia, and late-stage pipeline candidate APT-1011, according to…
Akums and Government of Zambia form joint venture to establish pharma manufacturing facility
The facility will produce essential medicines in Zambia and supply neighbouring African countries from 2028
Zydus Lifesciences hosts health symposium on new WHO influenza vaccination guideline for Northern…
Zydus Lifesciences convenes healthcare professionals in Bengaluru to discuss WHO’s updated influenza vaccination recommendations…
Thermo Fisher Scientific to expand biopharma manufacturing infrastructure in India
Company to establish Bioprocess Design Centre and Customer Experience Centre in Hyderabad by 2025 to strengthen India’s biopharma…
Japanese researchers develop cerium-based method to enable multiple chemical reactions in one vessel
A team from Chiba University introduces redox-adaptive auto-tandem catalysis, using cerium to sequentially perform two reactions…
Why pharma needs an HRMS built for continuous learning
In this article, Sonali Chowdhry highlights why the pharmaceutical industry needs a Human Resource Management System (HRMS)…
Trinity Challenge Awards £1 million to projects tackling antibiotic resistance in Africa
Com-WATCH in Nigeria and PADs across five African countries win £500,000 each to improve community access to effective antibiotics…
NITI Aayog highlights rare diseases challenge affecting 90 million Indians at FICCI national…
Stakeholders from government, parliament, industry, and patient groups call for indigenous drug development, stronger registries,…
Indian immunologicals pledges 5 lakh anti-rabies vaccine doses under CSR initiative
The company will provide veterinary anti-rabies vaccines for free roaming dogs as part of its support to the "One Health" mission